Does ACORAMIDIS Cause Product dose omission issue? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product dose omission issue have been filed in association with ACORAMIDIS (Attruby). This represents 3.9% of all adverse event reports for ACORAMIDIS.
9
Reports of Product dose omission issue with ACORAMIDIS
3.9%
of all ACORAMIDIS reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product dose omission issue From ACORAMIDIS?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACORAMIDIS. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ACORAMIDIS Cause?
Diarrhoea (67)
Abdominal discomfort (22)
Nausea (16)
Blood creatinine increased (15)
Fatigue (14)
Acute kidney injury (13)
Asthenia (12)
Abdominal pain (11)
Dizziness (11)
Abdominal pain upper (10)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ACORAMIDIS Alternatives Have Lower Product dose omission issue Risk?
ACORAMIDIS vs ACTEMRA
ACORAMIDIS vs ACTIQ
ACORAMIDIS vs ACTIVATED CHARCOAL
ACORAMIDIS vs ACTONEL
ACORAMIDIS vs ACYCLOVIR